Page 1503 - Williams Hematology ( PDFDrive )

1478 Part X: Malignant Myeloid Diseases Chapter 89: Chronic Myelogenous Leukemia and Related Disorders 1479

286. Kaur J, Catovsky D, Spiers AS, Galton DA: Increase of T-lymphocytes in the spleen in 321. Hagemeijer A, Bartram CR, Smith EME, et al: Is the chromosomal region 9q34
chronic granulocytic leukaemia. Lancet 1:834, 1974. always involved in variants of the Ph1 translocation? Cancer Genet Cytogenet 13:1,
287. Fujimiya Y, Bakke A, Chang WC, et al: Natural killer-cell immunodeficiency in 1984.
patients with chronic myelogenous leukemia. Int J Cancer 37:639, 1986. 322. De Braekeleer M, Chui HM, Fiser J, Gardner HA: A further case of Philadelphia chro-
288. Fujimiya Y, Chang WC, Bakke A, et al: Natural killer cell immunodeficiency in patients mosome-positive chronic myeloid leukemia with t(3;9;22). Cancer Genet Cytogenet
with chronic myelogenous leukemia. Cancer Immunol Immunother 24:213, 1987. 35:279, 1988.
289. Mellqvist UH, Hansson M, Brune M, et al: Natural killer cell dysfunction and apop- 323. Lafage-Pochitaloff-Huvalé M1, Sainty D, Adriaanssen HJ, et al: Translocation (3;21) in
tosis induced by chronic myelogenous leukemia cells: Role of reactive oxygen species Philadelphia positive chronic myeloid leukemia. Leukemia 3:554, 1989.
and regulation by histamine. Blood 96:1961, 2000. 324. Thompson PW, Whittaker JA: Translocation 3;21 in Philadelphia chromosome posi-
290. Pierson BA, Miller JS: The role of autologous natural killer cells in chronic myeloge- tive chronic myeloid leukemia at diagnosis. Cancer 39:143, 1989.
nous leukemia. Leukemia 11:1404, 1997. 325. Engel E, McGee BJ, Flexner JM, et al: Philadelphia chromosome (Ph1) translocation
291. Mason JE, DeVita VT, Canellos GP: Thrombocytosis in chronic granulocytic leuke- in an apparently Ph1 negative, minus G22, case of chronic myeloid leukemia. N Engl J
mia: Incidence and clinical significance. Blood 44:483, 1974. Med 291:154, 1974.
292. Pederson B: Kinetics and cell function, in Chronic Granulocytic Leukaemia, edited by 326. Verma RS, Dosik H: “Masked” Ph1 chromosome in chronic myelogenous leukaemia
Shaw MT, p 93. Praeger, East Sussex, UK, 1982. (CML). Blut 50:129, 1985.
293. Radhika V, Thennarasu S, Naik NR, et al: Granulocytes from chronic myeloid leuke- 327. Hagemeijer A, de Klein A, Godde-Salz E, et al: Translocation of c-abl to “masked” Ph
mia (CML) patients show differential response to different chemoattractants. Am J in chronic myeloid leukemia. Cancer Genet Cytogenet 18:95, 1985.
Hematol 52:155, 1996. 328. Melo JV: The diversity of BCR-ABL fusion proteins and their relationship to leukemic
294. Kasimir-Bauer S, Ottinger H, Brittinger G, König W: Philadelphia chromosome- phenotype. Blood 88:2375, 1996.
positive chronic myelogenous leukemia: Functional defects in circulating mature 329. O’Brien S, Thall PR, Siciliano MJ: Cytogenetics of chronic myeloid leukemia. Baillieres
neutrophils of untreated and interferon-α-treated patients. Exp Hematol 22:426, 1994. Clin Haematol 10:259, 1997.
295. Adams T, Schultz L, Goldberg L: Platelet function abnormalities in the myeloprolifer- 330. Bartram CR, Carbonell F: Bcr rearrangement in Ph-negative CML. Cancer Genet
ative disorders. Scand J Haematol 13:215, 1974. Cytogenet 21:183, 1986.
296. Gerrard JM, Stoddard SF, Shapiro RS, et al: Platelet storage pool deficiency and pros- 331. Bartram CR: Rearrangement of bcr and c-abl sequences in Ph-positive acute leuke-
taglandin synthesis in chronic granulocytic leukaemia. Br J Haematol 40:597, 1978. mias and Ph-negative CML—An update. Curr Stud Hematol Blood Transfus 31:160,
297. Knox WF, Bhavani M, Davson J, Geary CG: Histological classification of chronic 1987.
granulocytic leukemia. Clin Lab Haematol 6:171, 1984. 332. Ganesan TS, Rassool F, Guo A-P, et al: Rearrangement of the bcr gene in Philadelphia-
298. Lorand-Metze I, Vassalo J, Souza CA: Histological and cytological heterogeneity of chromosome negative chronic myeloid leukemia. Curr Stud Hematol Blood Transfus
bone marrow in Philadelphia-positive chronic myelogenous leukaemia at diagnosis. 31:153, 1987.
Br J Haematol 67:45, 1987. 333. Wiedemann LM, Karhi K, Chan LC: Similar molecular alterations occur in related
299. Inokuchi K, Yamaguchi H, Tarusawa M, et al: Abnormality of c-kit oncoprotein in leukemias with and without the Philadelphia chromosome. Curr Stud Hematol Blood
certain patients with chronic myelogenous leukaemia—Potential clinical significance. Transfus 31:149, 1987.
Leukemia 16:170, 2002. 334. Benn P, Loper L, Eisenberg A, et al: Utility of molecular genetic analysis of bcr rear-
300. Cairoli R, Grillo G, Beghini A, et al: Chronic myelogenous leukemia with acquired rangement in the diagnosis of chronic myeloid leukemia. Cancer Genet Cytogenet
c-kit activating mutation and transient bone marrow mastocytosis. Hematol J 5:273, 29:1, 1987.
2004. 335. Epner DE, Koeffler AP: Molecular genetic advances in chronic myelogenous leuke-
301. Agis H, Sotlar K, Valent P, Horny HP: Ph-chromosome-positive chronic myeloid leu- mia. Ann Intern Med 113:3, 1990.
kemia with associated bone marrow mastocytosis. Leuk Res 29:1227, 2005. 336. Dubé I, Dixon J, Beckett T, et al: Location of breakpoints within the major breakpoint
302. Kelsey PR, Geary CG: Sea-blue histiocytes and Gaucher’s cells in bone marrow of cluster region (bcr) in 33 patients with bcr rearrangement-positive chronic myeloid
patients with chronic myeloid leukaemia. J Clin Pathol 41:960, 1988. leukemia with complex or absent Philadelphia chromosomes. Genes Chromosomes
303. Dekmezian R, Kantarjian HM, Keating MJ, et al: The relevance of reticulin stain- Cancer 1:106, 1989.
measured fibrosis at diagnosis in chronic myelogenous leukemia. Cancer 59:1739, 337. Morris C, Heisterkamp N, Kennedy MA, et al: Ph-negative chronic myeloid leukemia:
1987. Molecular analysis of ABL insertion into M-BCR on chromosome 22. Blood 76:1812,
304. Ghosh K, Varma N, Varma S, Dash S: Cellular composition and reticulin fibrosis in 1990.
chronic myeloid leukaemia. Indian J Cancer 25:128, 1988. 338. Blennerhassett GT, Furth ME, Anderson A, et al: Clinical evaluation of DNA probe
305. Buhr T, Choritz H, Georgii A: The impact of megakaryocyte proliferation for the evo- assay for the Philadelphia (Ph1) translocation in chronic myelogenous leukemia. Leu-
lution of myelofibrosis. Virchows Arch 420:473, 1992. kemia 2:648, 1988.
306. Korkolopoulou P, Viniou N, Kavantzas N, et al: Clinicopathologic correlations of bone 339. Lange W, Snyder DS, Castro R, et al: Detection by enzymatic amplification of bcr-abl
marrow angiogenesis in chronic myeloid leukemia: A morphometric study. Leukemia mRNA in peripheral blood and bone marrow cells of patients with chronic myeloge-
17:89, 2003. nous leukemia. Blood 73:1735, 1989.
307. Aguayo A, Kantarjian H, Manshouri T, et al: Angiogenesis in acute and chronic leuke- 340. Dhingra K, Talpaz M, Riggs MC, et al: Hybridization protection assay: A rapid, sen-
mias and myelodysplastic syndromes. Blood 96:2240, 2000. sitive, and specific method for detection of Philadelphia chromosome-positive leuke-
308. Zhelyazkova AG, Tonchev AB, Kolova P, et al: Prognostic significance of hepatocyte mias. Blood 77:238, 1991.
growth factor and microvessel bone marrow density in patients with chronic myeloid 341. Stock W, Westbrook CA, Peterson B, et al: Value of molecular monitoring during the
leukaemia. Scand J Clin Lab Invest 18:1, 2008. treatment of chronic myeloid leukemia: A Cancer and Leukemia Group B study. J Clin
309. Rumpel M, Friedrich T, Deininger MW: Imatinib normalizes bone marrow vascularity Oncol 15:26, 1997.
in patients with chronic myeloid leukemia in first chronic phase. Blood 101:4641, 2003. 342. Frenoy N, Chabli A, Sol D, et al: Application of a new protocol for nested PCR to the
311. Udomsakdi C, Eaves CJ, Lansdorp PM, Eaves AC: Phenotypic heterogeneity of prim- detection of minimal residual bcr/abl transcripts. Leukemia 8:1411, 1994.
itive leukemic hematopoietic cells in patients with chronic myeloid leukemia. Blood 343. Melo JV, Yan XH, Diamond J, et al: Reverse transcription/polymerase chain reaction
80:2522, 1992. (RT/PCR) amplification of very small numbers of transcripts: The risk in misinter-
312. Huret JL: Complex translocations, simple variant translocation and Ph-negative cases preting negative results. Leukemia 10:1217, 1996.
in chronic myelogenous leukaemia. Hum Genet 85:565, 1990. 344. Lin F, Chase A, Bunget J, et al: Correlation between the proportion of Philadelphia
313. Sakurai M, Sandberg AA: The chromosomes and causation of human cancer and leu- chromosome-positive metaphase cells and levels of BCR-ABL mRNA in chronic mye-
kemia: XVIII. The missing Y in acute myeloblastic leukemia (AML) and Ph1-positive loid leukaemia. Genes Chromosomes Cancer 13:110, 1995.
chronic myelocytic leukemia. Cancer 38:762, 1976. 344A. Cortes J and Kantarjian H: How I treat newly diagnosed chronic phase CML. Blood
314. Berger R, Bernheim A: Y chromosome loss in leukemias. Cancer Genet Cytogenet 1:1, 120:1390, 2012.
1979. 345. Dewald GW, Schad CR, Christensen ER, et al: The application of in situ fluorescent
315. Ishihara T, Sasaki M, Oshimura M, et al: A summary of cytogenetic studies on 534 hybridization to detect M bcr/abl fusion in variant Ph chromosomes in CML and
cases of chronic myelogenous leukemia in Japan. Cancer Genet Cytogenet 9:81, 1983. ALL. Cancer Genet Cytogenet 71:7, 1993.
316. Mitelman F: Catalogue of chromosomal aberrations in cancer. Cytogenet Cell Genet 346. Cox MC, Maffei L, Buffolino S, et al: A comparative analysis of FISH, RT-PCR, and
36:9, 1983. cytogenetics for the diagnosis of bcr-abl-positive leukemias. Am J Clin Pathol 109:24,
317. Heim S, Billstrom R, Kristoffersson U, et al: Variant Ph translocations in chronic mye- 1998.
loid leukemia. Cancer Genet Cytogenet 18:215, 1985. 347. Sinclair PB, Green AR, Grace C, Nacheva EP: Improved sensitivity of BCR-ABL
318. Bartram CR, Anger B, Carbonell F, Kleihauer E: Involvement of chromosome 9 in detection: A triple-probe three-color fluorescence in situ hybridization system. Blood
variant Ph1 translocation. Leuk Res 9:1133, 1985. 90:1395, 1997.
319. Morris CM, Rosman I, Archer SA, et al: A cytogenetic and molecular analysis of five 348. Acar H, Stewart J, Boyd E, Connor MJ: Identification of variant translocations in
variant Philadelphia translocations in chronic myeloid leukemia. Cancer Genet Cyto- chronic myeloid leukemia by fluorescence in situ hybridization. Cancer Genet Cyto-
genet 35:179, 1988. genet 93:115, 1997.
320. Teyssier JR, Bartram CR, DeVille J, et al: C-abl oncogene and chromosome 22 “bcr” 349. Schoch C, Schnittger S, Bursch S, et al: Comparison of chromosome banding anal-
juxtaposition in chronic myelogenous leukemia. N Engl J Med 312:1393, 1985. ysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for

Kaushansky_chapter 89_p1437-1490.indd 1478 9/18/15 3:42 PM